| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9249697 | Gastrointestinal Endoscopy | 2005 | 9 Pages |
Abstract
Pretreatment with high-dose, orally administered allopurinol decreases the frequency of post-ERCP pancreatitis. Despite the promising results of this prospective, randomized trial, further studies are needed to verify these observations before allopurinol can be recommended for routine clinical use.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Panagiotis MD, Jannis MD, Josef MD, Kiriakos MD, George MD, Kostas MD, Athanasios MD, Christos MD,